Drug Guidance for Subsidy 08/02/2023 Echinocandins for treating invasive candidiasis The Ministry of Health’s Drug Advisory Committee has recommended: Anidulafungin 100 mg injec... See all × 08/02/2023 Echinocandins for treating invasive candidiasis The Ministry of Health’s Drug Advisory Committee has recommended: Anidulafungin 100 mg injection in line with its registered indications for treating invasive candidiasis in view of favourable clinical and cost-effectiveness compared with other echinocandins. Funding status RAnidulafungin 100 mg injection is recommended for inclusion on the MOH Standard Drug List (SDL) from 1 April 2023. NRSubsidy does not apply to micafungin 50 mg injection or caspofungin 50 mg and 70 mg injections.
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Injection, Powder, Lyophilized, For Solution 50 mg/vial KK Women's and Children's Hospital National University Hospital Singapore General Hospital
INTRAVENOUS Select a brand starting with the letter: M MYCAMINE POWDER FOR SOLUTION FOR INFUSION 50MG/VIAL [SIN14464P]